Multimodal functional and structural neuroimaging investigation of major depressive disorder following treatment with duloxetine

BMC Psychiatry

Volumn 15, Issue 1, 2015, Pages

  Fu, Cynthia ^a,b   Costafreda, Sergi G ^b,c   Sankar, Anjali ^b   Adams, Tracey M ^d   Rasenick, Mark M ^e,f   Liu, Peng ^g   Donati, Robert ^e,h   Maglanoc, Luigi A ⁱ   Horton, Paul ^b   Marangell, Lauren B ^j  

^a UNIVERSITY OF EAST LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d WARNEFORD HOSPITAL   (United Kingdom)

^e UNIVERSITY OF ILLINOIS   (United States)

^f JESSE BROWN VA MEDICAL CENTER   (United States)

^g ELI LILLY AND COMPANY   (United States)

^h ILLINOIS COLLEGE OF OPTOMETRY   (United States)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY OF TEXAS   (United States)

more..

Author keywords

Antidepressant; BOLD; Brain; Function; Predictor; Prognosis; Structure

Indexed keywords

DULOXETINE; SEROTONIN UPTAKE INHIBITOR; THIOPHENE DERIVATIVE;

ADULT; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; ATTENTIONAL BIAS; BRAIN ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEFAULT MODE NETWORK; DRUG EFFECT; FACIAL EXPRESSION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; MAJOR DEPRESSION; MALE; MULTIMODAL IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CINGULATE; RESTING STATE NETWORK; STROOP TEST; BRAIN; BRAIN MAPPING; DEPRESSIVE DISORDER, MAJOR; ECHO PLANAR IMAGING; EMOTION; LONGITUDINAL STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING;

ADULT; BRAIN; BRAIN MAPPING; DEPRESSIVE DISORDER, MAJOR; DULOXETINE HYDROCHLORIDE; ECHO-PLANAR IMAGING; EMOTIONS; FACIAL EXPRESSION; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; IMAGING, THREE-DIMENSIONAL; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; STROOP TEST; THIOPHENES;

EID: 84928635592     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-015-0457-2     Document Type: Article

References (55)

1. Diener C, Kuehner C, Brusniak W, Ubl B, Wessa M, Flor H. A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression. Neuroimage. 2012;61:677-85.
2. Hamilton JP, Etkin A, Furman DJ, Lemus MG, Johnson RF, Gotlib IH. Functional neuroimaging of major depressive disorder: a meta-analysis and a new integration of base line activation and neural response data. Am J Psychiatry. 2012;169:693-703.
3. Sheline YI, Barch DM, Donnelly JM, Ollinger JM, Snyder AZ, Mintun MA. Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry. 2001;50:651-8.
4. Fu CH, Williams SC, Cleare AJ, Brammer MJ, Walsh ND, Kim J, et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry. 2004;61:877-89.
5. Delaveau P, Jabourian M, Lemogne C, Guionnet S, Bergouignan L, Fossati P. Brain effects of antidepressants in major depression: a meta-analysis of emotional processing studies. J Affect Disord. 2011;130:66-74.
6. Fu CH, Mourao-Miranda J, Costafreda SG, Khanna A, Marquand A, Williams SCR, et al. Pattern classification of sad facial processing: toward the development of neurobiological markers in depression. Biol Psychiatry. 2008;63:656-62.
7. Fu CH, Steiner H, Costafreda SG. Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol Dis. 2013;52:75-83.
8. Sexton CE, Mackay CE, Ebmeier KP. A systematic review and meta-analysis of magnetic resonance imaging studies in late-life depression. Am J Geriatr Psychiatry. 2013;21:184-95.
9. Lisiecka D, Meisenzahl E, Scheuerecker J, Schoepf V, Whitty P, Chaney A, et al. Neural correlates of treatment outcome in major depression. Int J Neuropsychopharmacol. 2011;14:521-34.
10. Frodl T, Scheuerecker J, Schoepf V, Linn J, Koutsouleris N, Bokde AL, et al. Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. J Clin Psychiatry. 2011;72:448-57.
11. Outhred T, Hawkshead BE, Wager TD, Das P, Malhi GS, Kemp AH. Acute neural effects of selective serotonin reuptake inhibitors versus noradrenaline reuptake inhibitors on emotion processing: Implications for differential treatment efficacy. NeurosciBiobehav Rev. 2013;37:1786-800.
12. Wagner G, Koch K, Schachtzabel C, Sobanski T, Reichenbach JR, Sauer H, et al. Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression. J Psychiatry Neurosci. 2010;35:247-57.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
14. First MB, Spitzer RL, Gibbon M, Williams JW. Structured Clinical Interview for DSM-IV Axis I Disorders-Research Version, Patient Edition (SCID-I/P). New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1997.
15. Hamilton M. A rating scale for depression. J NeurolNeurosurg Psychiatry. 1960;23:56-62.
16. Hamilton M. Development of a rating scale for primary depressive illness. Br J SocClin Psychol. 1967;6:278-96.
17. Wechsler D. Wechsler Adult Intelligence Scale - 3rd UK Edition (WAIS®-III UK). Oxford, United Kingdom: Pearson UK; 1999.
18. Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168:1266-77.
19. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-5.
20. Guy W. ECDEU Assessment Manual for Psychopharmacology-Revised. Rockville, MD: National Institute of Mental Health, Psychopharmacology Research Branch; 1976.
21. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. IntClinPsychopharmacol. 1996;11:89S-95.
22. Fu CH, Williams SC, Cleare AJ, Scott J, Mitterschiffthaler MT, Walsh ND, et al. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry. 2008;64:505-12.
23. Fu CHY, Williams SCR, Brammer MJ, Suckling J, Kim J, Cleare AJ, et al. Neural responses to happy facial expressions in major depression following antidepressant treatment. Am J Psychiatry. 2007;164:599-607.
24. Mitterschiffthaler MT, Williams SCR, Walsh ND, Cleare AJ, Donaldson C, Scott J, et al. Neural basis of the emotional Stroop interference effect in major depression. Psychol Med. 2008;38:247-56.
25. Ekman P, Friesen WV. Pictures of Facial Affect. Palo Alto, CA: Consulting Psychologists Press; 1976.
26. Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage. 2012;61:1402-18.
27. Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. FSL. Neuroimage. 2012;62:782-90.
28. Beckmann CF, DeLuca M, Devlin JT, Smith SM. Investigations into resting-state connectivity using independent component analysis. Philos Trans R SocLond B Biol Sci. 2005;360:1001-13.
29. Andrews-Hanna JR, Reidler JS, Sepulcre J, Poulin R, Buckner RL. Functional-anatomic fractionation of the brain's default network. Neuron. 2010;65:550-62.
30. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci. 2008;1124:1-38.
31. Nichols TE, Holmes AP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp. 2002;15:1-25.
32. Smith SM, Nichols TE. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localization in cluster inference. Neuroimage. 2009;44:83-98.
33. Hudson JI, Wohlreich MM, Kajdasz DK, Mallinckrodt CH, Watkin JG, Martynov OV. Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trials. Hum Psychopharmacol. 2005;20:327-41.
34. Arnone D, McKie S, Elliott R, Thomas EJ, Downey D, Juhasz G, et al. Increased amygdala responses to sad but not fearful faces in major depression: relation to mood state and pharmacological treatment. Am J Psychiatry. 2012;169:841-50.
35. Costafreda SG, Brammer MJ, David AS, Fu CH. Predictors of amygdala activation during the processing of emotional stimuli: A meta-analysis of 385 pet and fmri studies. Brain Res Rev. 2008;58:57-70.
36. Victor TA, Furey ML, Fromm SJ, Öhman A, Drevets WC. Relationship between amygdala responses to masked faces and mood state and treatment in major depressive disorder. Arch Gen Psychiatry. 2010;67:1128-38.
37. 2O PET study of the neuromodulatory effects of clonidine. Biol Psychiatry. 2001;49:317-25.
38. Beck AT. Cognitive Therapy and the Emotional Disorders. Meridian: New York, NY; 1976.
39. MacLeod CM. Half a century of research on the Stroop effect: an integrative review. Psychol Bull. 1991;109:163-203.
40. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl AcadSci U S A. 2001;98:676-82.
41. Anand A, Li Y, Wang Y, Wu J, Gao S, Bukhari L, et al. Antidepressant effect on connectivity of the mood-regulating circuit: an fMRI study. Neuropsychopharmacology. 2005;30:1334-44.
42. Li B, Liu L, Friston KJ, Shen H, Wang L, Zeng LL, et al. A treatment-resistant default mode subnetwork in major depression. Biol Psychiatry. 2013;74:48-54.
43. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain StructFunct. 2008;213:93-118.
44. Fu CH, Costafreda SG. Neuroimaging-based biomarkers in psychiatry: clinical opportunities of a paradigm shift. Can J Psychiatry. 2013;58:499-508.
45. Greicius MD, Flores BH, Menon V, Glover GH, Solvason HB, Kenna H, et al. Resting-state functional connectivity in major depression: Abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry. 2007;62:429-37.
46. Berman MG, Peltier S, Nee DE, Kross E, Deldin PJ, Jonides J. Depression, rumination and the default network. SocCogn Affect Neurosci. 2011;6:548-55.
47. Zhu X, Wang X, Xiao J, Liao J, Zhong M, Wang W, et al. Evidence of a dissociation pattern in resting-state default mode network connectivity in first-episode, treatment-naive major depression patients. Biol Psychiatry. 2012;71:611-7.
48. Korgaonkar MS, Williams LM, Song YJ, Usherwood T, Grieve SM. Diffusion tensor imaging predictors of treatment outcomes in major depressive disorder. Br J Psychiatry. 2014;205:321-8.
49. Khalsa S, Mayhew SD, Chechlacz M, Bagary M, Bagshaw AP. The structural and functional connectivity of the posterior cingulate cortex: Comparison between deterministic and probabilistic tractography for the investigation of structure-function relationships. Neuroimage. 2014;102:118-27.
50. Sämann PG, Höhn D, Chechko N, Kloiber S, Lucae S, Ising M, et al. Prediction of antidepressant treatment response from gray matter volume across diagnostic categories. EurNeuropsychopharmacol. 2013;23:1503-15.
51. Arnone D, McKie S, Elliott R, Juhasz G, Thomas EJ, Downey D, et al. State-dependent changes in hippocampal grey matter in depression. Mol Psychiatry. 2012;18:1265-72.
52. Frodl T, Jäger M, Smajstrlova I, Born C, Bottlender R, Palladino T, et al. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci. 2008;33:423-30.
53. Bambico FR, Belzung C. Novel insights into depression and antidepressants: a synergy between synaptogenesis and neurogenesis? Curr Top BehavNeurosci. 2013;15:243-91.
54. Sauder CL, Hajcak G, Angstadt M, Phan KL. Test-retest reliability of amygdala response to emotional faces. Psychophysiology. 2013;50:1147-56.
55. Poppe AB, Wisner K, Atluri G, Lim KO, Kumar V, Macdonald 3rd AW. Toward a neurometric foundation for probabilistic independent component analysis of fMRI data. Cogn Affect BehavNeurosci. 2013;13:641-59.